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Retinoids, the active metabolites of vitamin A, regulate complex gene networks involved in vertebrate
morphogenesis, growth, cellular differentiation and homeostasis. Studies performed in vitro, using either
acellular systems or transfected cells, have shown that retinoid actions are mediated through heterodimers
between the RAR and RXR nuclear receptors. However, in vitro studies indicate what is possible, but not
necessarily what is actually occurring in vivo, because they are performed under non-physiological conditions.
Therefore, genetic approaches in the animal have been be used to determine the physiological functions of
retinoid receptors. Homologous recombination in embryonic stem cells has been used to generate germline
null mutations of the RAR- and RXR-coding genes in the mouse. As reviewed here, the generation of such
germline mutations, combined with pharmacological approaches to block the RA signalling pathway, has
provided genetic evidence that RAR/RXR heterodimers are indeed the functional units transducing the RA
signal during prenatal development. However, due to (i) the complexity in “hormonal” signalling through
transduction by the multiple RARs and RXRs, (ii) the functional redundancies (possibly artefactually generated
by the mutations) within receptor isotypes belonging to a given family, and (iii) in utero or early postnatal
lethality of certain germline null mutations, these genetic studies have failed to reveal all the physiological
functions of RARs and RXRs, notably in adults. Spatio-temporally-controlled somatic mutations generated
in given cell types/tissues and at chosen times during postnatal life, will be required to reveal all the functions
of RAR and RXR throughout the lifetime of the mouse.
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Introduction
Both clinical findings and experimental approaches have
revealed that vitamin A (retinol) and its active derivatives
(i.e., the retinoids) exert a wide variety of effects on
vertebrate embryonic body shaping and organogenesis,
tissue homeostasis, cell proliferation, differentiation and
apoptosis (reviewed in [Blomhoff, 1994; Kastner et al.,
1995; Mark et al., 2006; Morriss-Kay and Ward, 1999;
Sporn et al., 1994]). Following Hale’s initial demonstration
that vitamin A-deficiency (VAD) induces congenital ocular
malformations [Hale, 1933], Warkany and his
collaborators showed that a large array of congenital
malformations affecting the ocular, cardiac, respiratory
and urogenital systems (collectively referred as to the
fetal VAD syndrome) occurred in fetuses from vitamin
A-deficient (VAD) rats (reviewed in [Wilson et al., 1953]).
It was shown, much later, that retinoic acid (RA) could
replace vitamin A during embryogenesis, at least at
certain stages and in certain organs [Dickman et al., 1997;
White et al., 1998].
How RA can exert such pleiotropic effects was a
long-standing question, which found its solution with the
discovery of two classes of RA-binding transcriptional
regulators, the retinoic acid receptors (the multiple
isoforms of the RARα, β and γ isotypes), and the retinoid
X receptors (the multiple isoforms of the RXRα, β and γ
isotypes) (reviewed in [Chambon, 1996; Leid et al., 1992].
The present review focuses on three main questions: (i)
are RARs and RXRs involved in the transduction of RA
signals in vivo? (ii) to what extent do the observations
made in vivo support the molecular mechanisms deduced
from in vitro studies? (iii) what are the developmental
events controlled by RARs and RXRs? We summarize
and discuss in this review the developmental phenotypes
induced by mutations that have been introduced at loci
encoding RARs and RXRs, and compare them to the
phenotypes resulting either from VAD or from
administration of pharmacological doses of antagonistic
ligands for RARs in vertebrates, placing emphasis on
results obtained in mammals.
RARs and RXRs are instrumental to
retinoic acid signalling during
embryonic development
Signalling through RARs is indispensable for
embryonic patterning and organogenesis
Rara, Rarb, and Rarg null mutant mice are viable.They
display some aspects of the fetal (and postnatal) VAD
syndromes, as well as a few additional congenital
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are restricted to a subset of tissues normally expressing
these receptors, probably reflecting the existence of
functional redundancies between RARs (discussed in
[Kastner et al., 1995; Kastner et al., 1997a; Mark and
Chambon, 2003; Mark et al., 1995; Mascrez et al., 1998]).
To test this hypothesis, mutants lacking two RAR isotypes
(Rara/b-, Rara/g- and Rarb/g-null mutants), or several
isoforms belonging to distinct isotypes were generated.
For the sake of clarity, only abnormalities displayed by
double null mutants lacking a couple of RAR isotypes (all
isoforms deleted) are listed in Table 2 and Table 3. Similar
abnormalities, albeit often less penetrant, which are
displayed by "isoform-specific" double null mutants are
listed in [Kastner et al., 1995] (mutants lacking
RARα1/RARβ2/4, RARα1/RARγ, RARα1α2
+/-/RARγ and
RARβ2/4/RARγ), in [Subbarayan et al., 1997] (mutants
lacking RARα/RARγ1 and RARα/RARγ2), in [Luo et al.,
1996] (mutants lacking RARα1/RARβ), in [Ghyselinck et
al., 1998] (mutants lacking RARα/RARβ1/3 and
RARβ1/3/RARγ), and in [Grondona et al., 1996] (mutants
lacking RARβ2/RARγ2).
Rara/b-, Rara/g- and Rarb/g-null mutants die in utero or
at birth because of severe developmental defects that
altogether include the complete spectrum of
malformations belonging to the fetal VAD-induced
syndrome reported by Warkany’s group 55 years ago
[Wilson et al., 1953] (Table 2). As with Rar-single-null
mutants (see Table 1), Rar-double-null mutants (Table
3) also exhibit congenital abnormalities that were not
described in Hale’s and Warkany’s pioneering fetal VAD
studies [Hale, 1933;Wilson et al., 1953], encompassing
ageneses of the Harderian glands, skeletal defects of the
skull, face, vertebrae, limbs and forebrain [Ghyselinck et
al., 1997; Lohnes et al., 1993; Lohnes et al., 1994; Luo
et al., 1996; Mendelsohn et al., 1994; Subbarayan et al.,
1997].The occurrence of these “non-VAD” defects in Rar-
single and double-null mutant mice is most probably
accounted for by the difficulty to achieve, by dietary
deprivation, a state of profound VAD compatible with
pregnancy. In fact, almost all these “non-VAD” defects
have been subsequently produced in rodent embryos (i)
deficient in vitamin A, but supplemented with RA [Dickman
et al., 1997;White et al., 2000;White et al., 1998]; (ii)
deficient in both RBP (retinol-binding protein) and vitamin
A [Quadro et al., 2005]; (iii) lacking the retinaldehyde
synthesising enzyme RDH10 (retinol dehydrogenase 10)
[Sandell et al., 2007]; (iv) lacking the RA synthesising
enzymes RALDH2 (retinaldehyde dehydrogenase 2)
[Halilagic et al., 2007; Molotkova et al., 2007;
Niederreither et al., 2002a; Niederreither et al., 1999;
Niederreither et al., 2001; Niederreither et al., 2000;
Niederreither et al., 2002b; Ribes et al., 2006] or RALDH3
[Dupe et al., 2003; Halilagic et al., 2007] or (v) treated
with synthetic retinoids possessing panRAR antagonistic
activities [Kochhar et al., 1998;Wendling et al., 2000;
Wendling et al., 2001]. In addition, it was recently found
that the Matthew-Wood syndrome, which consists of a
spectrum of congenital abnormalities also observed in
Rara/b, Rara/g and Rarb/g-null mutants, is caused by
mutations in the RBP receptor gene, STRA6 [Golzio et
al., 2007; Pasutto et al., 2007]. As STRA6 loss-of-function
mutations most probably yield a state of RA insufficiency
in embryonic tissues [Kawaguchi et al., 2007], this
discovery provides evidence that RAR signalling performs
similar functions during embryonic development in mice
and humans.
The comparison of the Rar-null mutant phenotypes with
those of rodents and humans carrying the aforementioned
blocks in RA signal transduction, demonstrate that
liganded RARs play crucial roles at many distinct stages
of the development of numerous organs ([Kastner et al.,
1995] and references therein). For example, the severe
malformations found in Rara/g-null embryos [Wendling
et al., 2001] are similar to those of Aldh1a2 (formerly
Raldh2)-null embryos [Niederreither et al., 1999], and
reflect early roles of RAR signalling in axial rotation,
segmentation and closure of the hindbrain, formation of
otocysts, pharyngeal arches and forelimb buds, as well
as in closure of the primitive gut. RARs are also
indispensable for the ontogenesis of (almost) all the
anatomical structures that are derived from
mesectodermal cells, i.e. the cranial neural crest cells
(NCC) that give rise to mesenchymal derivatives
(reviewed in [Kastner et al., 1995; Mark et al., 1998; Mark
et al., 1995]). RARs are involved in antero-posterior
patterning of the somitic mesoderm and hindbrain
neurectoderm [Dupe et al., 1999b; Ghyselinck et al., 1997;
Lohnes et al., 1993; Lohnes et al., 1994;Wendling et al.,
2001], notably through controlling expression of
homeobox genes [Allan et al., 2001; Dupe et al., 1997;
Dupe et al., 1999b; Houle et al., 2000; Oosterveen et al.,
2003; Serpente et al., 2005]. RARs are also involved in
the establishment of the antero-posterior axis of the limbs
[Dupe et al., 1999a; Lohnes et al., 1994; Mascrez et al.,
1998]. RARs are required for the development of a large
number of eye structures (Table 2 and Table 3) and for
histogenesis of the retina [Ghyselinck et al., 1997;
Grondona et al., 1996; Lohnes et al., 1994],
cardiomyocyte differentiation [Kastner et al., 1994;
Kastner et al., 1997b], as well as for the control of
physiological apoptosis in the retina [Grondona et al.,
1996], the frontonasal and interdigital mesenchymes
[Crocoll et al., 2002; Dupe et al., 1999a; Ghyselinck et
al., 1997; Lohnes et al., 1994], the conotruncal segment
of the embryonic heart [Ghyselinck et al., 1998] and the
embryonic nephric duct [Batourina et al., 2005]. In the
embryonic urogenital tract, RARs control
epithelial-mesenchymal interactions in the kidney through
expression of the receptor tyrosine kinase Ret [Batourina
et al., 2002; Batourina et al., 2001; Mendelsohn et al.,
1999], as well as the formation of the genital ducts and
ureters [Batourina et al., 2001; Batourina et al., 2005;
Ghyselinck et al., 1997; Mendelsohn et al., 1994]. In the
developing respiratory tract, RA-liganded RARs are
necessary for the morphogenesis of the nasal cavities
and for their communication with the more caudal airways
[Dupe et al., 2003; Ghyselinck et al., 1997] (Table 2 and
Table 3). RA-liganded RARs are also required for the
partitioning of the primitive foregut into oesophagus and
trachea, and regulate lung branching morphogenesis
[Chen et al., 2007; Desai et al., 2006; Malpel et al., 2000;
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Review RAR and RXR functions in developmentTable 1.  Postnatal manifestations of germline ablation of Rar and Rxr genes. CD: congenital defects, PnVAD: abnormalities present in postnatal
vitamin A-deficiency (Wolbach and Howe, 1925); fetal VAD: abnormalities present in vitamin A-deficiency during pregnancy (Wilson et al., 1953). #:
these abnormalities are completely penetrant. Rara1, Rara2, Rarb1/3, Rarb2/4, Rarg1 and Rarg2 refer to isoform-specific ablations.
Mollard et al., 2000;Wang et al., 2006], as well as lung
alveoli septation [Massaro and Massaro, 2003; Massaro
et al., 2003; Massaro et al., 2000; McGowan et al., 2000]
(Table 1, Table 2, and Table 3).
Altogether, the developmental abnormalities of Rar-null
mutant mice faithfully recapitulate those of rodents lacking
the RAR ligand either through dietary vitamin A
deprivation or genetically-impaired RA synthesis.There
are, however, two notable exceptions to this rule which
are related to the control, through RA signalling, of (i) the
symmetry of somite patterning and (ii) germ cell
differentiation in the embryonic ovary. Concerning
somitogenesis, it has been firmly established, in several
vertebrate species, that RA is instrumental to the
generation of bilaterally symmetrical pairs of somites
[Echeverri and Oates, 2007; Kawakami et al., 2005; Sirbu
and Duester, 2006;Vermot and Pourquie, 2005]. It was
also recently demonstrated that signalling by RA is
required for expression of Stra8 (stimulated by retinoic
acid 8) which, in turn, triggers meiosis in the embryonic
ovary [Baltus et al., 2006; Bowles et al., 2006; Koubova
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Review RAR and RXR functions in developmentTable 2.  Abnormalities of the fetal vitamin A deficiency (VAD) syndrome (Wilson et al., 1953) present in Rarb-null mutants (Aβ), Rxra-null
mutants and in compound Rara/b-, Rara/g- and Rarb/g-null mutants. (Aα/Aβ, Aα/Aγ and Aβ/Aγ, respectively). #, this abnormality is completely
penetrant. NA, not applicable, as the corresponding structure is normally not found at E14.5, the time around which Rxra-null mutants die. From
references (Ghyselinck et al., 1997; Lohnes et al., 1994; Kastner et al., 1994). Note that most of the abnormalities seen in Rara/b-null mutants occur
at similar frequencies in Rara/b2-mutants (Mendelsohn et al., 1994).
et al., 2006]. However, defects in the symmetry of somite
derivatives, such as vertebrae and muscles, or in the
histology of the ovaries, were never observed in Rara/b-,
Rara/g- and Rarb/g-null mutant mice. As mentioned
above, the apparent lack of phenotypic convergence
between the animal models lacking RA and those lacking
RARs is probably a consequence of the artificial
compensation of the functions of the RARs that are
missing in the knockout mice by the remaining one.
RARs have been instrumental to the
phylogenesis of mesectodermal derivatives
In addition to the dramatic craniofacial skeletal
deficiencies affecting Rara/g-null mutants [Lohnes et al.,
1994], subtle defects which often alter the shape of a
single skeletal piece are observed in several Rar-null
mice, including: a cartilaginous or osseous connection
between the incus middle ear bone and the alisphenoid
bone (the pterygoquadrate element), a cartilage
separating the trigeminal ganglion from the brain (the pila
antotica) and an agenesis of the rostral ethmoturbinate
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Review RAR and RXR functions in developmentTable 3.  Abnormalities absent from the fetal vitamin A deficiency (VAD) syndrome are found in Rara-, Rarb- and Rarg-null mutants (Aα,
Aβ, Aγ), and in compound Rara/b-, Rara/g- and Rarb/g-null mutants (Aα/Aβ, Aα/Aγ and Aβ/Aγ). #: this abnormality is completely penetrant. From
references (Ghyselinck et al., 1997; Lohnes et al., 1994; Kastner et al., 1994). Note that most of the abnormalities seen in Rara/b-null mutants occur
at similar frequencies in Rara/b2-mutants (Mendelsohn et al., 1994).
and maxillary sinus (Table 3) [Ghyselinck et al., 1997;
Lohnes et al., 1994; Mark et al., 1998].The
pterygoquadrate element and the pila antotica, which
were lost during evolution from reptiles to mammals,
represent atavistic features (discussed in [Mark et al.,
1998; Mark et al., 1995]). Along the same lines,
ethmoturbinate bones and paranasal sinuses (such as
the maxillary sinus) are typical mammalian features not
present in reptiles [Novacek, 1993]. It is thus conceivable
that agenesis of these nasal structures in Rar-null mutants
also mimics an atavistic condition.The presence of
atavistic characteristics in Rar-null mutants supports the
possibility that changes in the temporal or spatial patterns
of expression of Rar genes has provided a general
mechanism for modifying the number and shape of
individual cranial skeletal elements during vertebrate
evolution. Interestingly, recent teratogenic experiments
using RA in excess have led to similar conclusions
[Vieux-Rochas et al., 2007].
The persistent and hyperplastic vitreous body (PHPV)
seen in Rarb-null mutants is comparable to the pecten
oculi, a normal vascular and pigmented projection from
the optic disk found in some reptiles, which is thought to
function in the nutrition of the retina [Mann, 1937].The
shortening of the ventral retina observed in Rarb/g-null
mutants might also be interpreted as a modification
towards an ancestral condition, since comparative
embryology of the retina shows that the ventral retinal
field increases in size as one ascends the vertebrate
scale from fishes to amphibia, reptiles and mammals
[Mann, 1937].Thus, RARβ and RARγ might have been
instrumental in the expansion of the ventral retinal field
during vertebrate evolution.
RXRα is the main RXR isotype involved in
embryogenesis
Rxra-null mutants all display a hypoplasia of the compact
layer of the ventricular myocardium (Table 2), which
appears to be the main cause of mutant death occurring
by cardiac failure around E14.5 [Kastner et al., 1994;
Kastner et al., 1997b; Ruiz-Lozano et al., 1998; Sucov et
al., 1994].That a similar myocardium defect is observed
in VAD and Rar-null fetuses [Mendelsohn et al., 1994;
Wilson et al., 1953], suggests that RXRα is involved in
the transduction of the RA signal required for myocardial
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cell-autonomous, as over-expressing RXRα in
cardiomyocytes by means of trangenesis does not prevent
the Rxra-null mutation-induced hypoplasia of the
ventricular myocardium [Subbarayan et al., 2000]. Other
data further indicate that Rxra expression in the
epicardium is required for triggering a paracrine signal
necessary for myocardial growth [Chen et al., 2002; Kang
and Sucov, 2005; Merki et al., 2005].
About one third of the Rxra-null mutants lack the
conotruncal septum, which normally divides the embryonic
heart outflow tract (or conotruncus) into the intracardiac
portions of the aorta and the pulmonary trunk [Kastner et
al., 1994]. Interestingly, deficiencies of this septum
represent both a classical VAD defect in rodents and a
leading cause of human congenital heart defects, ranging
from high interventricular septal defects to double outlet
right ventricle (DORV). In Rxra-null mutants, the agenesis
of the conotruncal septum appears secondary to an
enhanced rate of cell death in both the mesenchymal
cells of the conotruncal ridges and the parietal conotruncal
cardiomyocytes, therefore indicating that RXRα is
required for the transduction of the RA signal that controls
apoptosis in the conotruncal segment of the embryonic
heart [Ghyselinck et al., 1998].
In addition to heart defects, all Rxra-null fetuses display
a characteristic ocular syndrome characterized by a
PHPV, closer eyelid folds, a thickened ventral portion of
the corneal stroma, a ventral rotation of the lens, an
agenesis of the sclera and a shortening of the ventral
retina (Table 2) [Kastner et al., 1994]. As similar defects
are present in VAD fetuses and in Rarb/g-null mutants
(Table 2) [Ghyselinck et al., 1997;Wilson et al., 1953],
RXRα appears to play an essential role in the transduction
of the RA signals required for several ocular
morphogenetic processes, notably the formation of the
ventral retinal field.
Importantly, the fact that mice lacking both RXRβ and
RXRγ (Rxrb/g-null mutants) do not display any obvious
morphogenetic defects, even when additionally lacking
one allele of Rxra, clearly indicates that RXRα is
functionally the most important RXR during
morphogenesis of the embryo proper [Krezel et al., 1996].
The AF-1-containing A/B domain and the
ligand-dependent AF-2 of RXRα are differentially
involved in development
The role played by RXRs as either “active” or “silent”
heterodimerization partners in the transcription of target
genes, inferred from in vitro studies, has been a
controversial issue.To determine the transcriptional role
of RXRα in vivo, mouse mutants were engineered that
express truncated RXRα proteins lacking (i) the
N-terminal activation function (AF)-1-containing A/B region
(Rxra
af1o  mutants) [Mascrez et al., 2001], (ii) the AF-2
activating domain (AD) core-containing helix 12 located
at the C-terminus of the E region (Rxra
af2o  mutants)
[Mascrez et al., 1998] and (iii) both AF-1 and AF-2 (Rxra
afo
mutants) [Mascrez et al., 2009].
The Rxra
af2o  mutants display the myocardium hypoplasia
and the ocular syndrome that are hallmarks of the
Rxra-null phenotype [Kastner et al., 1994], but at low
frequency [Mascrez et al., 1998].This may reflect a
functional compensation by RXRβ, as (i) the frequency
of the myocardium hypoplasia increases from 5% in
Rxra
af2o  mutants to 50% upon the additional inactivation
of Rxrb (which, on its own, has no effect) [Kastner et al.,
1996], and (ii) the frequency of the ocular syndrome
increases from about 15% in Rxra
af2o  mutants to 100%
upon further inactivation of Rxrb [Mascrez et al., 1998].
The full penetrance of the Rxra-null ocular syndrome
observed in Rxra
af2o/Rxrb-null mutants [Mascrez et al.,
1998], as well as in Rxra
afo  mutants [Mascrez et al.,
2009], supports the view that the AF-2 of RXRα (and thus
possibly a RXR agonistic ligand) is indispensable for
ocular morphogenesis. On the other hand, the rare or
modest penetrance of the myocardium hypoplasia in
Rxra
af2o  (5%), Rxra
af2o/Rxrb-null (50%) and
Rxra
af2o/Rxrb/g-null mutants (50%) suggests that the
transcriptional activity of RXRα becomes necessary for
myocardial growth only in “unfavourable” genetic
backgrounds. Accordingly, we recently found that the
heart histology is normal in 80% of Rxra
afo  fetuses
[Mascrez et al., 2009], indicating that a transcriptionally
“silent” RXRα can promote myocardial growth.
Involution of the primary vitreous body represents the
developmental process which likely requires the highest
concentration of RA-liganded retinoid receptors, since
both VAD [Wilson et al., 1953], Rarb ablation [Ghyselinck
et al., 1997], Rxra ablation [Kastner et al., 1994], deletion
of RXRα AF-2 [Mascrez et al., 1998] and deletion of
RXRα AF-1 and AF-2 [Mascrez et al., 2009] frequently
yield a PHPV. Apart from an occasional PHPV, the
Rxra
af1o  mutants never display any of the Rxra-null
developmental defects [Mascrez et al., 2001].This
near-absence of defects does not reflect a functional
compensation by RXRβ or RXRγ, as Rxra
af1o/Rxrb-null
and Rxra
af1o/Rxrb/g-null mutants display no other
developmental defect than a PHPV. However, the
frequency of this PHPV increases from 10% in Rxra
af1o
mutants to 100% in Rxra
af1o/Rxrb/g-null mutants [Mascrez
et al., 2001]. Altogether, these observations indicate that
involution of the primary vitreous body requires both
RXRα AF-1 and AF-2, while the other RA-dependent
ocular morphogenetic events require RXRα AF-2 only,
as they normally take place in the absence of the RXRα
AF-1-containing A/B domain.
Thus, these data support the view that the activation
functions of RXRα are differentially required for eye
morphogenesis and that they can be dispensable for heart
development.They also indicate that, due to functional
redundancy, the role played by each activation function
can be revealed only in genetic backgrounds impaired
for RA-signalling (or under RA-insufficiency conditions).
Assuming that the frequent requirement of RXRα AF-2
for developmental events reflects the binding of an
agonistic ligand, this raises the question of the possible
existence and nature of a physiological RXR ligand(s) in
vivo.The fact that 9-cis RA is undetectable in rodent
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makes it doubtful that this RXR physiological ligand could
be 9-cis RA (reviewed in [Wolf, 2006]; see also [Calleja
et al., 2006]).
The RXRα AF-1-containing A/B domain has a
specific function in the involution of the
interdigital mesenchyme
The AF-2 of RXRα appears functionally more important
during development than its AF-1, as (i)
Rxra
af2o/Rxrb/g-null fetuses all display a large array of
congenital defects and die in utero, while
Rxra
af1o/Rxrb/g-null fetuses display only a few congenital
defects and are often viable; and (ii) transcription of a
RA-responsive lacZ reporter transgene in the mouse
requires RXRα AF-2, but not AF-1 [Mascrez et al., 1998;
Mascrez et al., 2001]. However, the RXRα
AF-1-containing A/B region has a unique role in the
RA-dependent disappearance of the interdigital
mesenchyme.
The first evidence implicating RA in the involution of the
interdigital mesenchyme was provided by organ culture
experiments using whole limb in a RA-deprived medium
[Lussier et al., 1993]. Subsequently, it was shown that
mice lacking both alleles of either Rara or Rarg, as well
as mice heterozygous for the Rxra-null mutation
occasionally exhibit mild forms of interdigital webbing
(i.e., soft tissue syndactyly) (Table 1) [Ghyselinck et al.,
1997; Kastner et al., 1994; Lohnes et al., 1993; Lufkin et
al., 1993]. Surprisingly, this defect was absent in Rarb-null
mutants, even though Rarb is strongly and specifically
expressed in the interdigital necrotic zones (INZs)
[Ghyselinck et al., 1997]. However, disruption of one (or
both) allele(s) of Rarb in a Rarg-null genetic background
consistently yields interdigital webbing [Ghyselinck et al.,
1997].The persistence of the fetal interdigital
mesenchyme responsible for digit webbing is caused by
a marked decrease in programmed cell death, as well as
by an increase of cell proliferation in the mutant INZs
[Dupe et al., 1999a]. As Rarb and Rarg are not
co-expressed in the INZs, interdigital mesenchyme
involution must involve paracrine interactions between
this mesenchyme, which expresses Rarb, and either the
cartilaginous blastema of the digits or the surface
epidermis, which both express Rarg (discussed in [Dupe
et al., 1999a]).
The RXRα AF-1-containing A/B region is indispensable
for the function of RXRα/RARβ and/or RXRα/RARγ
heterodimers involved in interdigital mesenchyme
involution, since the majority of Rxra
af1o  mutants and all
Rxra
af1o/Rxrb/g-null mutants display a soft tissue
syndactyly [Mascrez et al., 2001]. In contrast, Rxra
af2o
and Rxra
af2o/Rxrb/g-null mutants never display this defect
[Mascrez et al., 1998], indicating a specific requirement
of the RXRα AF-1-containing A/B region in the involution
of the interdigital mesenchyme. Interestingly,
phosphorylation of RXRα at a specific serine residue
located in the A domain is necessary for the
anti-proliferative response of F9 teratocarcinoma cells to
RA [Bastien et al., 2002; Rochette-Egly and Chambon,
2001]. Phosphorylation of the RXRα A domain may
therefore play an important function in the cascade of
molecular events that, in vivo, leads to the normal
disappearance of the interdigital mesenchyme.
Retinoic acid signals are transduced by specific
RXRα/RAR heterodimers during development
Compound mutants, in which a null mutation of a given
RAR isotype is associated either with a Rxra-null, a
Rxra
af1o  or a Rxra
af2o  mutation, altogether recapitulate
the abnormalities exhibited by Rar-null mutants (Table
4) [Kastner et al., 1994; Kastner et al., 1997a; Mascrez
et al., 1998; Mascrez et al., 2001].This synergism
between Rar and Rxra loss-of-function mutations supports
the conclusion that RXRα/RARα, RXRα/RARβ and
RXRα/RARγ heterodimers are the functional units
transducing RA signals during embryogenesis. Moreover,
that Rxrb/g-null mutants develop normally indicates that
RXRα is functionally the most important RXR isotype
during development [Krezel et al., 1996].This conclusion
is further supported by a lack of synergism, during
embryogenesis, between Rara-, Rarb- or Rarg-null
mutations and Rxrb- or Rxrg-null mutations [Kastner et
al., 1997a].
Comparing the severity and penetrance of a given
abnormality between various mutants led to the
identification of heterodimers preferentially involved in
transducing RA signals in a given developmental process.
For instance, myocardium hypoplasia is found in none of
the Rxra
af1o  mutants and in 5% of the Rxra
af2o  mutants.
It is observed in 45% of the Rxra
af1o/Rara-null and in 80%
of the Rxra
af2o/Rara-null mutants, but in none of the
Rxra
af1o/Rarb-null or Rxra
af1o/Rarg-null mutants and in
only 20% of the Rxra
af2o/Rarb-null or Rxra
af2o/Rarg-null
mutants [Mascrez et al., 1998; Mascrez et al., 2001].
Together, these genetic data indicate that RXRα/RARα
heterodimers are preferentially transducing the RA signal
acting on myocardial growth.
Similarly, although all three RARs are expressed in
developing ocular structures [Mori et al., 2001], several
lines of evidence indicate the involvement of RXRα/RARβ
and RXRα/RARγ but not of RXRα/RARα heterodimers
during eye morphogenesis. Firstly, there is a strong
synergism between Rxra- and Rarb- or Rarg-null
mutations, which is manifested by a marked increase in
the severity of the Rxra-null ocular defects, whereas no
synergism is observed with the Rara-null mutation (Table
4) [Kastner et al., 1997a]. Secondly, there is also a strong
synergism between the Rarb- or Rarg-null mutations and
ablation of either the AF-1-containing A/B domain or the
AF-2 of RXRα for the generation of ocular defects (Table
4) [Mascrez et al., 1998; Mascrez et al., 2001]. In fact,
apart from the PHPV discussed above, the characteristic
Rxra-null ocular syndrome is never observed in Rxra
af1o
mutants and is found in less than 15% of the Rxra
af2o
mutants. On the other hand, this ocular syndrome is
observed in 100% of the Rxra
af1o/Rarb-null,
Rxra
af1o/Rarg-null, Rxra
af2o/Rarb-null and Rxra
af2o/Rarg-null
mutants, while it is absent in all Rxra
af1o/Rara-null and
Rxra
af2o/Rara-null mutants [Mascrez et al., 1998; Mascrez
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Review RAR and RXR functions in developmentTable 4.  Evidence that RXRα and RAR act synergistically in embryonic development. Similar congenital defects absent (or very rare) in
Rxra-null, Rxra
af1o , Rxra
af2o , and Rara-, Rarb-, Rarg-null mutants are observed in compound Rxra/Rara-, Rxra/Rarb-, and Rxra/Rarg-null mutants
(Xα/Aα, Xα/Aβ and Xα/Aγ), in compound Rxra
af2o/Rara-, Rxra
af2o/Rarb-, and Rxra
af2o/Rarg-null mutants (Xαaf2o/Aα, Xαaf2o/Aβ and Xαaf2o/Aγ), in
compound Rxra
af1o/Rara-, Rxra
af1o/Rarb-, and Rxra
af1o/Rarg-null mutants (Xαaf1o/Aα, Xαaf1o/Aβ and Xαaf1o/Aγ), as well as in compound Rara/b-,
Rara/g- and Rarb/g-null mutants (Aα/Aβ, Aα/Aγ and Aβ/Aγ). *: this abnormality is present in a majority of the mutants. #: this abnormality is fully penetrant.
VAD, these abnormalities belong to the fetal vitamin A deficiency syndrome (Wilson et al., 1953). From references (Kastner et al., 1997a and 1997b;
Mascrez et al., 1998; Kastner et al., 1994; Mascrez et al., 2001).
et al., 2001]. Altogether, these genetic data indicate that
RXRα/RARβ and RXRα/RARγ are the heterodimers which
are instrumental to ocular morphogenesis.
Pharmacological and somatic
mutagenesis approaches provide clues
on RAR-controlled mechanisms
operating in the head region during
development
The endoderm of branchial arches is the target
of RA action mediated by RARα and/or RARβ
Rara/b-null mutants, analysed at fetal stages of gestation,
display the complete set of defects that can be generated
in the chick by surgical ablation of post-otic NCC, namely
thymus and parathyroid gland ageneses or ectopias,
aberrant patterning of cephalic arteries, absence of
pulmonary arteries and aorticopulmonary septum
([Ghyselinck et al., 1997; Mark et al., 1998; Mendelsohn
et al., 1994]and references therein).These defects are
also present in the CATCH22 syndrome, which is an
archetype of human neurocristopathy (i.e., congenital
malformations of NCC-derived structures).These and
other observations led to the proposal that cranial NCC
giving rise to mesenchymal derivatives (i.e., the
mesectodermal cells) are major targets of RA action
(reviewed in [Mark et al., 2004]).
Unexpectedly, Rara/b-null mutants analysed at embryonic
stages of gestation display very small caudal branchial
arches (BA), but do not show NCC alterations [Dupe et
al., 1999b]. BA are transient bulges of the embryonic
head and neck, partially filled with NCC, and separated
from one another by evaginations of the endoderm, the
pharyngeal pouches. Caudal BA and pouches give rise
to the adult organs affected in the aforementioned NCC
ablation experiments. As the BA defects observed in
Rara/b-null embryos are less severe than those displayed
by embryos lacking RALDH2 (i.e., embryos devoid of RA)
[Niederreither et al., 1999], they do not reflect a complete
block in RA signal transduction.To analyse NCC
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pouches, in a situation where the degree of the block in
RA signal transduction could be precisely controlled, a
culture system was designed in which wild-type embryos
are exposed, at selected times, to the panRAR antagonist
BMS493 [Wendling et al., 2000].
Treatment with BMS493, induces a lack of caudal BA
and pharyngeal pouches, and slightly disturbs the paths
of post-otic NCC migration, without affecting the amount
of NCC. Moreover, and most interestingly, this treatment
inhibits caudal BA development only during a narrow
window of time, which does not correspond to the period
of post-otic NCC migration.Thus, contrary to what was
expected from the set of abnormalities displayed by
Rara/b-null fetuses [Dupe et al., 1999b], migrating NCC
destined for the caudal BA do not represent exclusive
primary targets of RA action. On the other hand,
BMS493-induced alterations in endodermal expression
of “patterning” genes and of genes encoding peptides
involved in paracrine signalling pathways indicate that
RA signalling (i) is required to specify the pharyngeal
endoderm, and (ii) may provide a permissive environment
for NCC migration through secretion of specific paracrine
factors by the pharyngeal endoderm [Mark et al., 2004;
Wendling et al., 2001].These data also raise the
possibility that genes responsible for the human
CATCH22 syndrome are actually expressed in the
endoderm, under the control of RA during the fourth and
fifth weeks of gestation.
RARs act on top of a genetic cascade controlling
hindbrain segmentation
The embryonic hindbrain is transiently divided into
segments (rhombomeres), of which seven (R1 to R7) are
visible in mammals. Although early and transient,
hindbrain segmentation is instrumental to organize adult
structures such as cranial nerves.The hindbrain of
Rara/g-null embryos shows a posterior expansion of R3
and R4 markers, but fails to express kreisler, a specific
marker of R5 and R6 [Wendling et al., 2001]. In contrast,
the neurectodermal territory corresponding to R5 and R6
is markedly enlarged in Rara/b-null embryos [Dupe et al.,
1999b].Treating embryonic day (E)7.0 wild-type embryos
with the panRAR antagonist BMS493 duplicates the
abnormal hindbrain phenotype of Rara/g-null embryos,
while BMS493 administration started at E8.0 results in a
Rara/b-null-like phenotype [Wendling et al., 2000].
Therefore, the distinct phenotypes in Rara/b- and
Rara/g-null embryos are related to RA actions during
different windows of time. At E7.5 (when RA synthesis
begins in the embryo) [Niederreither et al., 1999], RARγ
and RARα transduce a signal required to specify the
R5/R6 territory. At E8.0, RARβ and RARα mediate a local
increase in RA signalling in the posterior portion of the
hindbrain to control the position of the R6 caudal
boundary, thus allowing the next caudal rhombomere,
R7, to be specified [Mark et al., 2004; Serpente et al.,
2005;Wendling et al., 2000].
That the expression domains of several important
hindbrain patterning genes are altered in Rara/b- and
Rara/g-null embryos provides evidence that RA acts on
top of the genetic hierarchy controlling hindbrain
patterning [Wendling et al., 2001]. Moreover, generation
of a graded embryonic block in RA signal transduction
through varying the concentrations of the panRAR
antagonist in the cultures, demonstrates that individual
rhombomeres are specified by distinct thresholds of RA
signalling, and support the view that RA acts as a
posteriorizing signal for the patterning of the embryonic
hindbrain ([Dupe and Lumsden, 2001; Serpente et al.,
2005;Wendling et al., 2001]and references therein).
Threshold levels of RA signalling can be set up through
modulations of the expression levels of RAR or of
RA-synthesising and catabolising enzymes (RALDHs and
CYP26s, respectively) [Abu-Abed et al., 2001; MacLean
et al., 2001; Niederreither et al., 2000;Tahayato et al.,
2003; Uehara et al., 2007].
Retinoic acid-dependent eye morphogenesis is
orchestrated by the neural crest
As mentioned above, Rarb/g-, Rxra/Rarb- and
Rxra/Rarg-null mutants, but not Rxra/Rara-null mutants,
display similar, albeit much more severe ocular defects
than Rxra-null mutants, indicating that RXRα/RARβ and
RXRα/RARγ heterodimers are instrumental to the
morphogenesis of eye structures, including the ventral
retina (Table 2, Table 3, and Table 4). Both Rarb and
Rarg are expressed in the periocular mesenchyme
(POM), but not in the retina [Ghyselinck et al., 1997; Mori
et al., 2001].Therefore, RA signalling in the POM (a
NCC-derived tissue) may be instrumental to the
morphogenesis of the retina (a neuroectoderm-derived
tissue). Using a somatic mutagenesis approach (reviewed
in [Metzger and Chambon, 2001]), we have recently
demonstrated that selective excision of both Rarb and
Rarg genes in POM precursor cells (Rarb/g
NCCα/α mutants)
recapitulates the eye defects generated upon germline
ablation of the same receptor genes. In POM cells,
RXRα/RARβ and RXRα/RARγ heterodimers appear to
control the extent of cell-death involved in POM
remodelling and the expression of Foxc1 and Pitx2 genes
[Matt et al., 2005a], which play crucial roles the
development of the anterior eye segment in mice and
humans [Cvekl and Tamm, 2004]. Interestingly, the POM
does not express any RA-synthesizing enzymes
(RALDHs), and is therefore unable to synthesise RA.
Instead, the neural retina, the retinal pigment epithelium
and the corneal ectoderm express both RALDH1 and
RALDH3 ([Matt et al., 2005a] and references therein).
The fact that in mutants lacking both RALDH1 and
RALDH3 (i) the activity of a RA-sensitive reporter
transgene is abolished in the POM and (ii) the ocular
defects that are generated recapitulate those observed
in Rarb/g-null mutants establishes that these two
RA-synthesizing enzymes provide the RA required to
activate RXRα/RARβ and RXRα/RARγ heterodimers in
the POM.Therefore, in the developing eye, RA acts as
a paracrine signal: it is synthesised by epithelial
compartments (i.e., the retina, retinal pigment epithelium
and corneal ectoderm), but exerts its effect on the
mesenchymal compartment (i.e., the POM). Conversely,
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the RA signal by synthesising a yet unknown paracrine
factor required for the growth of the ventral retina [Matt
et al., 2005a; Matt et al., 2008].
Conclusions and perspectives
The phenotypic analyses of mutants lacking retinoid
receptors have provided compelling evidence that RA is
actually the metabolite of vitamin A, which is active during
early embryogenesis, organogenesis, as well as
postnatally.This conclusion was subsequently
strengthened by the demonstration that RA, synthesized
by the retinaldehyde dehydrogenases (RALDH1, RALDH2
and RALDH3), acts as an indispensable developmental
hormone [Dupe et al., 2003; Matt et al., 2005a; Mic and
Duester, 2003; Mic et al., 2002; Mic et al., 2003; Mic et
al., 2004; Niederreither et al., 2002a; Niederreither et al.,
1999; Niederreither et al., 2001; Niederreither et al., 2000;
Niederreither et al., 2002b;Vermot et al., 2003].
Furthermore, the results from genetic and
pharmacological studies conducted in the mouse have
proven that the molecular mechanisms underlying
transduction of the RA signal by retinoid receptors, which
were suggested from in vitro studies, are actually
instrumental to retinoid signalling under physiological
conditions.They have also conclusively established that
the teratogenic effects resulting from administration of
exogenous RA to embryos do not reflect the physiological
role of endogenous RA in the corresponding
developmental processes (discussed in [Mark et al.,
2006]).
RXRα/RAR heterodimers are clearly the main functional
units transducing RA signals during development, and
specific heterodimers are involved in given developmental
processes (reviewed in [Mark and Chambon, 2003]).This
strongly supports the initial proposal that the pleiotropic
effects of RA reflect sophisticated combinatorial
mechanisms, through which multiple RXR/RAR
heterodimers differentially transduce retinoid signals to
selectively control the expression of numerous sets of
RA target genes [Leid et al., 1992]. Secondly, in vivo, the
RXR partner can be either transcriptionally active (thus
acting in synergy with its RAR partner) or inactive within
RXR/RAR heterodimers, depending on the developmental
event under consideration.Thirdly, the transcriptional
activity of RXR is subordinated to ligand binding to the
RAR partner in vivo [Elmazar et al., 2001; Matt et al.,
2003; Mic et al., 2003], as is the case in cultured cells in
vitro [Durand et al., 1994; Rochette-Egly and Chambon,
2001; Roy et al., 1995], and when RXRα is
transcriptionally active, either one or both activation
functions (AF-1 and AF-2) can be involved, their activity
depending on the nature of the RA-controlled
developmental event [Mascrez et al., 2009; Mascrez et
al., 1998; Mascrez et al., 2001].
The genetic studies summarized in this review have
revealed an extensive functional redundancy within the
members of each family (RARs or RXRs), although each
of these members appears to individually exert at least
one specific physiological function. Since the members
of each family share a common ancestor [Escriva et al.,
2004], such a redundancy is not surprising. However, it
raises the question as to whether it is physiologically
relevant or artefactually generated when a given receptor
is missing, as is the case in cultured F9 cells
[Rochette-Egly and Chambon, 2001;Taneja et al., 1995;
Taneja et al., 1996]. In this respect, note that the
existence of two fully redundant genes is, in an
evolutionary sense, unlikely [Brookfield, 1992;Thomas,
1993]. It is also noteworthy that the occurrence of a given
morphological defect in Rar double-null mutants
contrasting with its absence in Rar single-null mutants
should not be taken as a definite proof of a
cell-autonomous functional redundancy. Another possible
explanation could imply the action of distinct RARs in
different tissues, which may independently direct the
making of a given structure. Such a possibility may apply
to the case of the interdigital soft tissue, which involutes
normally in all Rarb- and in almost all Rarg-null mutants,
but persists in all Rarb/g-null mutants yielding webbed
digits (Table 1 and Table 3). In this instance, a functional
cell-autonomous redundancy between RARβ and RARγ
is hardly conceivable, as Rarb and Rarg exhibit
non-overlapping expression patterns in the limbs
[Ghyselinck et al., 1997].
Importantly, there is much less functional redundancy in
RXRα/RAR compound mutants (Table 2, Table 3, and
Table 4). As RXRα/RAR heterodimers are the functional
transducing units, the easiest way to interpret these
observations is to postulate that redundancy occurs only
when a single partner of the “physiological heterodimer”
is missing [Kastner et al., 1997a; Mascrez et al., 1998;
Mascrez et al., 2001]. In other words, the activity of the
“alternative heterodimer” may still be above the functional
threshold level when either the RXR or the RAR partner
of the “physiological heterodimer” is missing, but not when
both are deleted. According to this interpretation, the
selective involvement of a given RAR or RXR could be
revealed only under conditions where the functional
threshold level is not reached.This would notably account
for the observations that the role of the RXRα AF-1 or
AF-2 cannot be fully revealed, unless the activity of the
“physiological heterodimer” is altered by the additional
ablation of either the RAR partner or the redundant RXR
isotypes [Mascrez et al., 1998; Mascrez et al., 2001].
Thus, any conditions which would lower the activity of
RXR/RAR heterodimers (for instance a decreased
availability of RA), may reduce or abrogate functional
redundancy. As the supplies in vitamin A, the precursor
of RA, could be more limiting in wild-life than in the
context of an animal facility, the functional redundancies
between RAR and RXR may therefore be much less
prominent in natural environments.
Quite surprisingly, RXR loss-of-function mutants do not
display defects in morphogenesis other than those
observed in the fetal VAD syndrome or upon ablation of
the RA-synthesizing enzymes.This suggests that RXRs
are involved in morphogenesis solely through their
heterodimerization with RARs. Accordingly, mice
harbouring null mutations for the other nuclear receptors
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known (i.e., PPARα, PPARβ, TRα, TRβ, VDR, LXRα,
LXRβ, FXR, PXR, CAR) do not display morphological
abnormalities [Flamant and Samarut, 2003; Kato, 2000;
Lee and Gonzalez, 1996; Peet et al., 1998; Peters et al.,
2000; Sinal et al., 2000; Staudinger et al., 2001;Wei et
al., 2000; Xie et al., 2001], with the exception of
PPARγ-null mice [Barak et al., 1999]. In this latter case,
the embryonic heart defect is clearly secondary to a
severe placental hypoplasia [Barak et al., 1999].Thus,
amongst the multiple “hormone-like” signals that RXR/NR
heterodimers can integrate, RA appears to be the most
crucial, if not the only one involved in morphogenesis of
the embryo proper.
The genetic approach summarized in this review has
provided valuable insights on the functions of RA
receptors during development. However, this strategy
has intrinsic limitations, which are mostly due to the
introduction of mutations in the germline. First, the effect
of a germline mutation may be functionally compensated
for during development, thus precluding the appearance
of a defect. On the other hand, the mutation can be lethal
in utero (e.g., the Rxra knockout and the RAR compound
null mutants), thus preventing analysis of the functions
of the gene at postnatal stages.The mutation can also
arrest the development of a given organ at an early stage,
thus precluding further analysis of the gene functions at
a later stage. Moreover, introducing mutations in germline
makes it difficult to distinguish cell-autonomous from
non-cell autonomous functions of genes belonging to
families, such as RARs and RXRs that are involved in
pleiotropic signalling pathways. In many instances, these
limitations may actually prevent the determination of the
function of a given gene product in a defined cell
type/tissue and/or at a given time of the life of the animal.
This is obviously the case for RARs and RXRs.
To overcome all these limitations, strategies for
spatio-temporally-controlled somatic mutagenesis of
RARs and RXRs in mice have been designed, which are
based on the cell type-specific expression of a
tamoxifen-inducible form of the Cre recombinase (called
Cre-ER
T and Cre-ER
T2) (reviewed in [Metzger and
Chambon, 2001; Metzger et al., 2003]).The combined
use of transgenic mice expressing chimeric
tamoxifen-inducible Cre recombinases in specific cell
types and of mouse lines harbouring loxP-flanked
conditional alleles for RAR and RXR genes will provide
invaluable models to elucidate the postnatal functions of
retinoid receptors.
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